Novel Therapeutic Approach for Excitatory/Inhibitory Imbalance in Neurodevelopmental and Neurodegenerative Diseases.

Ghatak, Swagata; Talantova, Maria; McKercher, Scott R; Lipton, Stuart A

Ghatak, Swagata; Talantova, Maria; McKercher, Scott R; Lipton, Stuart A.

Afiliação

Ghatak S; Department of Molecular Medicine and Neuroscience Translational Center, The Scripps Research Institute, La Jolla, California 92037, USA; email: slipton@scripps.edu.
Talantova M; Department of Molecular Medicine and Neuroscience Translational Center, The Scripps Research Institute, La Jolla, California 92037, USA; email: slipton@scripps.edu.
McKercher SR; Department of Molecular Medicine and Neuroscience Translational Center, The Scripps Research Institute, La Jolla, California 92037, USA; email: slipton@scripps.edu.
Lipton SA; Department of Molecular Medicine and Neuroscience Translational Center, The Scripps Research Institute, La Jolla, California 92037, USA; email: slipton@scripps.edu.

Annu Rev Pharmacol Toxicol ; 61: 701-721, 2021 01 06.

Article em En | MEDLINE | ID: mdl-32997602

Assuntos

Transtorno do Espectro Autista; Doenças Neurodegenerativas; Encéfalo; Humanos; Neurônios

Palavras-chave

NMDA receptor antagonists; NMDA receptors; NitroSynapsin; excitatory/inhibitory imbalance; neurological disorders

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas / Transtorno do Espectro Autista Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google